The latest price target for Surgery Partners (NASDAQ:SGRY) was reported by JP Morgan on December 3, 2024. The analyst firm set a price target for $28.00 expecting SGRY to rise to within 12 months (a possible 31.95% upside). 26 analyst firms have reported ratings in the last year.

The latest analyst rating for Surgery Partners (NASDAQ:SGRY) was provided by JP Morgan, and Surgery Partners maintained their neutral rating.

The last upgrade for Surgery Partners Inc happened on November 14, 2023 when TD Cowen raised their price target to $35. TD Cowen previously had a market perform for Surgery Partners Inc.

The last downgrade for Surgery Partners Inc happened on June 15, 2022 when B of A Securities changed their price target from N/A to $36 for Surgery Partners Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Surgery Partners, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Surgery Partners was filed on December 3, 2024 so you should expect the next rating to be made available sometime around December 3, 2025.

While ratings are subjective and will change, the latest Surgery Partners (SGRY) rating was a maintained with a price target of $38.00 to $28.00. The current price Surgery Partners (SGRY) is trading at is $21.22, which is out of the analyst’s predicted range.